Visual decline in pediatric survivors of brain tumors following radiotherapy.
James E BatesDaniel J IndelicatoChristopher G MorrisRonny L RotondoJulie A BradleyPublished in: Acta oncologica (Stockholm, Sweden) (2020)
Visual acuity decline following radiotherapy for intracranial malignancies in children is rare. A dose of approximately 56 GyRBE to 0.1 cm3 results in an approximately 5% risk of visual acuity decline for children with suprasellar or optic pathway tumors. A dose to 0.1 cm3 of 56 GyRBE appears to be safe for children with tumors elsewhere in the brain.